Skip to main content
. 2019 Feb 8;10(4):598–605. doi: 10.1039/c9md00036d

Fig. 5. The effect of (A) glucose, galactose and mannose modified berberine derivatives (1, 2 and 3) and (B) rhamnose and ribose modified berberine derivatives (4 and 5) on the HepG2 cell viability. Data is expressed as means ± SD; n = 3.

Fig. 5